As of Apr 28
| +0.73 / +0.90%|
The 21 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 90.00, with a high estimate of 101.00 and a low estimate of 69.00. The median estimate represents a +9.68% increase from the last price of 82.06.
The current consensus among 23 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.